These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 18269639

  • 1. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, Wajchenberg BL, Rocha DM, Rondon MU, Negrão CE, Ursich MJ.
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [Abstract] [Full Text] [Related]

  • 2. The effects of metformin and glibenclamide on glucose metabolism, counter-regulatory hormones and cardiovascular responses in women with Type 2 diabetes during exercise of moderate intensity.
    Cunha MR, da Silva ME, Machado HA, Fukui RT, Correa MR, Santos RF, Wajchenberg BL, Rondon MU, Negrão CE, Ursich MJ.
    Diabet Med; 2007 Jun; 24(6):592-9. PubMed ID: 17381497
    [Abstract] [Full Text] [Related]

  • 3. The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.
    Gao H, Xiao W, Wang C, Zhang J, Yang Y, Yang J, Yang W, Hong T.
    Int J Clin Pract; 2008 May; 62(5):695-700. PubMed ID: 18412932
    [Abstract] [Full Text] [Related]

  • 4. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
    Medina Santillán R, Reyes-García G, Mateos-García E.
    Proc West Pharmacol Soc; 2002 May; 45():139-40. PubMed ID: 12434559
    [No Abstract] [Full Text] [Related]

  • 5. Normal insulin response to short-term intense exercise is abolished in Type 2 diabetic patients treated with gliclazide.
    Szewieczek J, Dulawa J, Strzałkowska D, Batko-Szwaczka A, Hornik B.
    J Diabetes Complications; 2009 May; 23(6):380-6. PubMed ID: 18394931
    [Abstract] [Full Text] [Related]

  • 6. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 7. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
    Medina Santillán R, Reyes-García G, Mateos-García E.
    Proc West Pharmacol Soc; 2002 Aug; 45():137-8. PubMed ID: 12434558
    [No Abstract] [Full Text] [Related]

  • 8. Metformin decreases platelet superoxide anion production in diabetic patients.
    Gargiulo P, Caccese D, Pignatelli P, Brufani C, De Vito F, Marino R, Lauro R, Violi F, Di Mario U, Sanguigni V.
    Diabetes Metab Res Rev; 2002 Aug; 18(2):156-9. PubMed ID: 11994908
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus.
    Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Liapis CD, Alevizos M.
    Diabet Med; 2008 Mar; 25(3):333-40. PubMed ID: 18307460
    [Abstract] [Full Text] [Related]

  • 10. Total and acylated ghrelin levels in type 2 diabetic patients: similar levels observed after treatment with metformin, pioglitazone or diet therapy.
    Kiyici S, Ersoy C, Oz Gul O, Sarandol E, Demirci M, Tuncel E, Sigirli D, Erturk E, Imamoglu S.
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):386-90. PubMed ID: 19629933
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of the short-term, intense exercise on postprandial glycemia in type 2 diabetic patients treated with gliclazide.
    Szewieczek J, Dulawa J, Strzałkowska D, Hornik B, Kawecki G.
    J Diabetes Complications; 2007 Sep; 21(2):101-7. PubMed ID: 17331858
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Aspects of antihyperglycemic oral bitherapy in 76 cases of non insulindependent diabetes in Dakar].
    Sidibé EH, Badiane MK, Gueye A.
    Sante; 2002 Sep; 12(3):319-22. PubMed ID: 12473527
    [Abstract] [Full Text] [Related]

  • 15. Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.
    Kraemer de Aguiar LG, Laflor CM, Bahia L, Villela NR, Wiernsperger N, Bottino DA, Bouskela E.
    Diabet Med; 2007 Mar; 24(3):272-9. PubMed ID: 17263761
    [Abstract] [Full Text] [Related]

  • 16. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ, Goldenberg N, Sieve L, Wang P.
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
    Yener S, Comlekci A, Akinci B, Demir T, Yuksel F, Ozcan MA, Bayraktar F, Yesil S.
    Med Princ Pract; 2009 Jul; 18(4):266-71. PubMed ID: 19494532
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
    Formoso G, De Filippis EA, Michetti N, Di Fulvio P, Pandolfi A, Bucciarelli T, Ciabattoni G, Nicolucci A, Davì G, Consoli A.
    Diabetes Metab Res Rev; 2008 Jul; 24(3):231-7. PubMed ID: 17966969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.